Drug Development Pharma - May 8, 2014
SARomics enters alliance with Swiss firm
SARomics Biostructures has entered into a strategic drug discovery partnership with inSili.com. The two companies are to perform collaborative research with the goal of finding novel bioactive agents against therapeutic drug targets. The focus of the collaboration aims at identifying new lead- and drug-like molecular entities with innovative modes of action, and obtaining structures of […]
Pharma Diagnostics - May 7, 2014
Dako launches ready-to-use antibodies for cancer diagnosis
The company adds two new antibodies to the Dako portfolio of reagents, instruments and software. The two antibodies are Anti-CK 8/18 and Anti-TdT. Anti-CK 8/18 is the first rabbit monoclonal antibody cocktail for cytokeratin 8/18 (CK 8/18) available from a major pathology provider. It is used by pathologists to stain CK 8/18 in tissue samples and […]
Agreement - May 7, 2014
Sectra signs agreement with University Hospitals in Cleveland
The University Hospitals are to invest in dose monitoring solution from Sectra as part of large multi-year agreement. The order includes a radiation dose monitoring solution and a five-year extension of the hospital’s service and support contract for its medical IT solutions provided by Sectra. University Hospitals is one of Sectra’s largest customers in the US as […]
Clinical Trials - May 6, 2014
Hansa Medical gets green light for kidney study
The Swedish Medical Products Agency has approved Hansa Medical’s clinical phase II-study application with the drug candidate IdeS. The study’s primary objective is to investigate IdeS’ efficacy and safety in sensitised kidney transplantation patients. The Phase II-study will be conducted at Uppsala University Hospital and is scheduled to begin in the second quarter of 2014. The […]
In a new job - May 6, 2014
Mårtensson to leave CellaVision
Cellavision’s CEO Yvonne Mårtensson is leaving after 16 years at the company. Yvonne Mårtensson remains CEO until a successor is appointed or until 31 December 2014 at the latest. “I have had the privilege of being part of this exciting journey that started sixteen years ago. Together with fantastic colleagues I was able to take CellaVision […]
Uncategorized - May 5, 2014
Karolinska Institutet gets new lab
Construction group Skanska has signed a deal with Akademiska Hus to build a new laboratory for Karolinska Institutet. The order regards the building of a ninth floor laboratory for medical research at the Karolinska Institute Campus in Solna, north of Stockholm, and will contain approximately a total of 17 000 squaremeteter work space. The laboratory […]
